ApoE ε2/ε3/ε4 polymorphism, ApoC-III/ApoE ratio and metabolic syndrome

Clinical and Experimental Medicine

Volumn 7, Issue 4, 2007, Pages 164-172

  Olivieri, O ^a   Martinelli, N ^a   Bassi, A ^a   Trabetti, E ^a   Girelli, D ^a   Pizzolo, F ^a   Friso, S ^a   Pignatti, P F ^a   Corrocher, R ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

ApoC III ApoE ratio; ApoE genotype; Metabolic syndrome

Indexed keywords

ANTILIPEMIC AGENT; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ALLELE; ARTERY DISEASE; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DNA POLYMORPHISM; FEMALE; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; METABOLIC SYNDROME X; PRIORITY JOURNAL; BLOOD; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED;

ADULT; AGED; APOLIPOPROTEIN C-III; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEINS E; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 38149100301     PISSN: 15918890     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10238-007-0142-y     Document Type: Article

References (41)

1. Song Y, Stampfer MJ, Liu S (2004) Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med 141:137-147
2. Paik YK, Chang DJ, Reardon CA et al (1985) Nucleotide sequence and structure of the human apolipoprotein E gene. Proc Natl Acad Sci U S A 82:3445-3449
3. Greenow K, Pearce NJ, Ramji DP (2005) The key role of apolipoprotein E in atherosclerosis. J Mol Med 83:329-342
4. Mahley RW, Rall SC Jr (2000) Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 1:507-537
5. Dallongeville J, Lussier-Cacan S, Davignon J (1992) Modulation of plasma triglyceride levels by ApoE phenotype: a meta-analysis. J Lipid Res 33:447-454
6. Ordovas JM, Schaefer EJ (2000) Genetic determinants of plasma lipid response to dietary intervention: the role of the APOA1/C3/A4 gene cluster and the ApoE gene. Br J Nutr 83[Suppl 1]:S127-136
7. Mahley RW, Ji ZS (1999) Remnant lipoprotein metabolism: key pathways involving cell-surface heparin sulfate proteoglycans and apolipoprotein E. J Lipid Res 40:1-16
8. van den Elzen P, Garg S, Leon L et al (2005) Apolipoprotein-mediated pathways of lipid antigen presentation. Nature 437:906-910
9. Zhang SH, Reddick RL, Piedrahita JA, Maeda N (1992) Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258:468-471
10. Zhang SH, Reddick RL, Burkey B, Maeda N (1994) Dietinduced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption. J Clin Invest 94:937-945
11. Meir KS, Leitersdorf E (2004) Atherosclerosis in the apolipoprotein-E- deficient mouse: a decade of progress. Arterioscler Thromb Vasc Biol 24:1006-1014
12. Morrow JA, Segall ML, Lund-Katz S et al (2000) Differences in stability among the human apolipoprotein E isoforms determined by the amino-terminal domain. Biochemistry 39:11657-11666
13. Cohn JS, Marcoux C, Davignon J (1999) Detection, quantification, and characterization of potentially atherogenic triglyceride-rich remnant lipoproteins. Arterioscler Thromb Vasc Biol 19:2474-2486
14. Sing CF, Davignon J (1985) Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet 37:268-285
15. Jong MC, Hofker MH, Havekes LM (1999) Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3. Arterioscler Thromb Vasc Biol 19:472-484
16. McConathy WJ, Gesquiere JC, Bass H et al (1992) Inhibition of lipoprotein lipase activity by synthetic peptides of apolipoprotein C-III. J Lipid Res 33:995-1003
17. Ginsberg HN, Le NA, Goldberg IJ et al (1986) Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. J Clin Invest 78:1287-1295
18. Kawakami A, Aikawa M, Alcaide P et al (2006) Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells. Circulation 114:681-687
19. Hodis HN, Mack WJ (1998) Triglyceride-rich lipoproteins and progression of atherosclerosis. Eur Heart J 19[Suppl A]:A40-44
20. Sacks FM, Alaupovic P, Moye LA et al (2000) VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial. Circulation 102:1886-1892
21. Cohn JS, Patterson BW, Uffelman KD et al (2004) Rate of production of plasma and very-low-density lipoprotein (VLDL) apolipoprotein C-III is strongly related to the concentration and level of production of VLDL triglyceride in male subjects with different body weights and levels of insulin sensitivity. J Clin Endocrinol Metab 89:3949-3955
22. Olivieri O, Stranieri C, Bassi A et al (2002) ApoC-III gene polymorphisms and risk of coronary artery disease. J Lipid Res 43:1450-1457
23. Olivieri O, Bassi A, Stranieri C et al (2003) Apolipoprotein CIII, metabolic syndrome, and risk of coronary artery disease. J Lipid Res 44:2374-2381
24. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486-2497
25. Zee RY, Cook NR, Cheng S et al (2004) Polymorphism in the P-selectin and interleukin-4 genes as determinants of stroke: a population-based, prospective genetic analysis. Hum Mol Genet 13:389-396
26. Eichner JE, Dunn ST, Perveen G et al (2002) Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol 155:487-495
27. Scuteri A, Najjar SS, Muller D et al (2005) ApoE4 allele and the natural history of cardiovascular risk factors. Am J Physiol Endocrinol Metab 289:E322-327
28. Hallman DM, Boerwinkle E, Saha N et al (1991) The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet 49:338-349
29. Hiukka A, Fruchart-Najib J, Leinonen E et al (2005) Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetes. Diabetologia 48:1207-1215
30. Tian Y, Long SY, Xu YH et al (2005) Study on ApoE gene polymorphism and subclasses of serum high density lipoprotein in type IV hyperlipidemia [in Chinese]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 22:96-98
31. Tilly P, Sass C, Vincent-Viry M et al (2003) Biological and genetic determinants of serum apolipoprotein CIII concentration. Reference limits from the Stanislas Cohort. J Lipid Res 44:430-436
32. Stephan ZF, Gibson JC, Hayes KC (1986) The apo E/apo CIII molar ratio affects removal of cholesterol ester from modified human lipoproteins injected into cebus monkeys. Life Sci 38:1383-1392
33. Gregg RE, Zech LA, Schaefer EJ et al (1986) Abnormal in vivo metabolism of apolipoprotein E4 in humans. J Clin Invest 78:815-821
34. Bergeron N, Havel RJ (1996) Prolonged postprandial responses of lipids and apolipoproteins in triglyceride-rich lipoproteins of individuals expressing an apolipoprotein epsilon 4 allele. J Clin Invest 97:65-72
35. Cardona F, Morcillo S, Gonzalo-Marin M, Tinahones FJ (2005) The apolipoprotein E genotype predicts postprandial hypertriglyceridemia in patients with the metabolic syndrome. J Clin Endocrinol Metab 90:2972-2975
36. Stiefel P, Montilla C, Muniz-Grijalvo O et al (2001) Apolipoprotein E gene polymorphism is related to metabolic abnormalities, but does not influence erythrocyte membrane lipid composition or sodium-lithium countertransport activity in essential hypertension. Metabolism 50:157-160
37. de Knijff P, Boomsma DI, Feskens EJ et al (1994) Apolipoprotein E phenotype and blood pressure. Lancet 343:1234-1235
38. Uusitupa M, Sarkkinen E, Kervinen K, Kesaniemi YA (1994) Apolipoprotein E phenotype and blood pressure. Lancet 343:57
39. Yilmaz H, Isbir T, Agachan B, Aydin M (2001) Is epsilon4 allele of apolipoprotein E associated with more severe endorgan damage in essential hypertension? Cell Biochem Funct 19:191-195
40. Li X, Du Y, Du Y, Huang X (2003) Association of apolipoprotein E gene polymorphism with essential hypertension and its complications. Clin Exp Med 2:175-179
41. Paris D, Town T, Parker TA et al (1998) Isoform-specific vasoconstriction induced by apolipoprotein E and modulation of this effect by Alzheimer's beta-amyloid peptide. Neurosci Lett 256:73-76